Nurse Practitioner, Family · San Antonio, TX
NPI
1104152826
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5107 Medical Dr
San Antonio, TX, 78229
Phone (210) 614-8612
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.5M
5,000 prescriptions
Company payments, 2025
$3,054
From 29 companies
Medicare prescription drug claims, 2024
In 2024, the drug Andrea C Milam prescribed most often to Medicare patients was Levothyroxine Sodium, with 392 prescriptions and refills. In total Andrea C Milam wrote 5,000 Medicare prescriptions that cost $3.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 392 | 1,155 | 173 | $5,152 |
| Ozempic Semaglutide | 362 | 546 | 105 | $507K |
| Mounjaro Tirzepatide | 349 | 387 | 86 | $400K |
| Atorvastatin Calcium Generic | 300 | 876 | 136 | $3,003 |
| Rosuvastatin Calcium Generic | 199 | 592 | 86 | $3,100 |
| Jardiance Empagliflozin | 167 | 420 | 61 | $237K |
| Metformin Hcl Generic | 143 | 424 | 67 | $1,379 |
| Metformin Hcl Er Metformin Hcl | 142 | 414 | 64 | $1,544 |
| Trulicity Dulaglutide | 140 | 241 | 51 | $238K |
| Farxiga Dapagliflozin Propanediol | 131 | 278 | 48 | $148K |
| Losartan Potassium Generic | 104 | 295 | 54 | $1,044 |
| Lisinopril Generic | 98 | 294 | 45 | $887 |
| Glimepiride Generic | 76 | 222 | 37 | $648 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 73 | 214 | 37 | $14K |
| Amlodipine Besylate Generic | 71 | 214 | 36 | $478 |
Brand drugs: 2,348 claims; generic drugs: 2,370 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrea C Milam $3,054 ($3,054 in general payments such as food, travel and fees) from 29 companies. The largest payer was Sanofi-Aventis U.S. LLC with $343.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 17 | $343 |
| Sequel Med Tech, LLC | 32 | $275 |
| Lilly USA, LLC LLY | 14 | $258 |
| Ascensia Diabetes Care Us Inc. | 31 | $240 |
| Amgen Inc. AMGN | 15 | $219 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $193 |
| Novo Nordisk Inc NVO | 10 | $190 |
| Mannkind Corporation MNKD | 12 | $162 |
| Corcept Therapeutics CORT | 7 | $135 |
| Abbott Laboratories ABT | 7 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.